LSLukasz Szumowski

Lukasz Szumowski

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Lukasz Szumowski has a total of 126 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Risk factors of atrial fibrillation recurrence despite successful radiofrequency ablation of accessory pathway: At 11 years of follow-up

    by Michał Orczykowski, Piotr Urbanek, Robert Bodalski, Paweł Derejko, Grzegorz Warmiński, Małgorzata Łodyga, Damian Łasocha, Łukasz Mazurkiewicz, Maciej Dąbrowski, Paweł Tyczyński, et al.

    Background: Previous reports on patients with radiofrequency catheter ablation (RFCA) of accessory pathway (AP) and atrial fibrillation (AF) include only short follow-up periods. The aim of this study was to analyse predictors of recurrence of AF in patients after successful RFCA of APs over long term follow-up periods. Methods: Of the 1,007 patients who underwent non-pharmacological treatment of Aps ( between the years 1993–2008), data of 100 consecutive patients were retrospectively analyzed (75 men, mean age 43.6 ± 14.7), with the longest period of follow-up (mean 11.3 ± 3.5 years) after successful RFCA of AP. In Group 1, there were 72 patients (54 M, mean age 40.66 ± 13.85 years) without documented episodes of AF after RFCA of AP. Group 2 consisted of 28 patients (21 men, mean age 50.79 ± 14.49 years) with AF episodes despite successful elimination of AP. Results: In univariate analysis, patients from Group 1 were significantly younger at the time of ablation than patients from Group 2 (40.66 ± 13.85 vs. 50.79 ± 14.49 years; p = 0.002), had shorter history of AF episodes (4.11 ± 4.07 vs. 8.25 ± 7.50 years; p = 0.024) and had more frequently documented atrial tachycardia (AT) prior to ablation (3.39 vs. 20.00 years; p = 0.022). In multivariate analysis, the history of AF in years (p = 0.043), was an independent risk factor for AF recurrences. Conclusions: Older patient age, longer history of AF and AT prior to RFCA of APs identified a subgroup of patients who required additional treatment. In the multivariate analysis, the history of AF in years (p = 0.043) was a risk factor for AF recurrence. Background: Previous reports on patients with radiofrequency catheter ablation (RFCA) of accessory pathway (AP) and atrial fibrillation (AF) include only short follow-up periods. The aim of this study was to analyse predictors of recurrence of AF in patients after successful RFCA of APs over long term follow-up periods. Methods: Of the 1,007 patients who underwent non-pharmacological treatment of Aps ( between the years 1993–2008), data of 100 consecutive patients were retrospectively analyzed (75 men, mean age 43.6 ± 14.7), with the longest period of follow-up (mean 11.3 ± 3.5 years) after successful RFCA of AP. In Group 1, there were 72 patients (54 M, mean age 40.66 ± 13.85 years) without documented episodes of AF after RFCA of AP. Group 2 consisted of 28 patients (21 men, mean age 50.79 ± 14.49 years) with AF episodes despite successful elimination of AP. Results: In univariate analysis, patients from Group 1 were significantly younger at the time of ablation than patients from Group 2 (40.66 ± 13.85 vs. 50.79 ± 14.49 years; p = 0.002), had shorter history of AF episodes (4.11 ± 4.07 vs. 8.25 ± 7.50 years; p = 0.024) and had more frequently documented atrial tachycardia (AT) prior to ablation (3.39 vs. 20.00 years; p = 0.022). In multivariate analysis, the history of AF in years (p = 0.043), was an independent risk factor for AF recurrences. Conclusions: Older patient age, longer history of AF and AT prior to RFCA of APs identified a subgroup of patients who required additional treatment. In the multivariate analysis, the history of AF in years (p = 0.043) was a risk factor for AF recurrence.


  • Characteristic features of patients with multiple accessory pathways

    by Michal Orczykowski, Pawel Derejko, Piotr Urbanek, Robert Bodalski, Joanna Zakrzewska-Koperska, Maria Bilińska, Lukasz Szumowski

    Objective Only limited clinical and electrophysiological data concerning patients (pts) with multiple accessory pathways (MAP) in comparison to large control groups are available. The aim of our study was to analyse these data from the largest cohort of patients with multiple accessory pathways and a large control group. Method and results We analysed data from pts with MAP (group 1) and pts with a single accessory pathway (AP) (group 2) referred for radiofrequency catheter ablation (RFCA) at our tertiary centre. Group 1 consisted of 124 pts (M 62.10%, mean age 33.00 ± 5.26) with MAP and RFCA. Group 2 consisted of 376 pts (M 51.20%, mean age 35.87 ± 16.15) with a single accessory pathway and RF ablation. Group 1 exhibited a higher incidence of overt APs (P < 0.0001), Ebstein anomaly (P = 0.001), ventricular fibrillation (P = 0.012), antidromic atrioventricular re-entrant tachycardia (A AVRT) (P = 0.025) and male gender (P = 0.038). The mean age at the first documented atrioventricular re-entrant tachycardia (AVRT) episode was lower in pts with MAP than in pts with single APs: 16.79 ± 13.41 vs 20.84 ± 14.29, respectively (P = 0.001). Concealed accessory pathways (P < 0.0001) occurred more frequently in the control group. Group 1 had more right-lateral (P = 0.0001), mid-septal (P = 0.0001), left-posterior (P = 0.01), left-anterior (P = 0.013) and left-lateral localizations of AP (P < 0.037). Conclusions The MAP group included statistically significantly more men, Ebstein anomaly and overt APs. The mean age of the first episode of atrioventricular re-entrant tachycardia was lower in pts with MAP. Certain distribution patterns are apparent for single and MAP. Pts with MAP are at higher risk of VF and antidromic atrioventricular re-entrant tachycardia.


    • 1 January 2015
      • Vol. 72  (4) , 178-83

    [Cardiac abnormalities in patients with myotonic dystrophy--preliminary results].

    by Paweł Derejko, Marta Banach, Andrzej Hasiec, Jakub Antczak, Rafał Rola, Radosław Sierpiński, Jolanta Miśko, Anna Wójcik, Roman Kępski, Lukasz Szumowski

    Myotonic dystrophy (DM) is an inherited multisystem disorder associated with myotonia, progressive skeletal muscle weakness and atrophy, involvement of peripheral and central nervous system and sudden death likely due to atrioventricular block and/or ventricular arrhythmia. to assess the type and degree of cardiac and neurological involvement in patients (pts) with DM. 10 pts (6 male), in mean age of 35 +/- 13 years, treated for DM type I (DM1)--7 pts and type II (DM2)--3 pts. All pts underwent a neurological examination including muscle strength assessment as well as cardiac diagnostics including: standard and 48-hour ambulatory electrocardiogram, echocardiographic examination, magnetic resonance imaging (MRI) of the heart and late potentials assessment. Muscle strength was moderately diminished (46-48 points in MRC sub score) in 3 pts with DM1 and mildly diminished (56-58 points in MRC sub score) in 2 pts with DM2. These patients showed clinical symptoms of myopathy. Cardiovascular examinations revealed: QRS duration above 110 ms in 5 pts, clinically significant supraventricular arrhythmia or atrioventricular block in 3 pts, focal myocardial fibrosis in 3 pts, asymmetric hypertrophy of inter-ventricular septum in 1 patient, presence of late potentials in 5 pts. We have not observed correlation between impaired muscle strength and cardiac abnormalities. However, most pronounced cardiac abnormalities were observed in 2 male DM1 patients with clinical symptoms of myopathy and lowest MRC score. At a mean follow up of 3.2 +/- 1.4 years none of the pts died. Cardiac involvement in pts with myotonic dystrophy is frequent and is characterized by phenotypic heterogeneity. Detection of cardiac abnormalities may require extensive diagnostics. The most important is the assessment of ECG. Cardiac and neurological abnormalities vary in intensity between patients without close relationship to each other.

    • 1 January 2013
      • Vol. 71  (1) , 17-24

    Catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: atrial fibrillation type determines the success rate.

    by Paweł Derejko, Magdalena Polańska, Lidia Chojnowska, Ilona Michałowska, Anna Wójcik, Ewa Piotrowicz, Agnieszka Lech, Mariusz Kłopotowski, Rafał Baranowski, Andrzej Przybylski, et al.

    Atrial fibrillation (AF) in patients with hypertrophic cardiomyopathy (HCM) is generally associated with deterioration of the clinical status, functional capacity, and quality of life. It is also an independent risk factor for stroke and death. Studies evaluating the effectiveness of AF ablation in this cohort are relatively scant, have included relatively few patients, and their results are somewhat conflicting. Thus, the aim of this study was to assess the safety and efficacy of catheter ablation of AF in patients with HCM. Thirty patients (10 females; mean age 48.7 ± 11 years) with drug-refractory paroxysmal (n = 14), persistent (n = 7), or long-persistent (> 1 year; n = 9) AF were prospectively recruited into the study. Eleven patients were in New York Heart Association (NYHA) class I, 13 patients were in NYHA class II, and 6 patients were in NYHA class III. Mean atrial volume was 180 ± 47 mL, interventricular septum thickness was 20.5 ± 6.3 mm, and left atrial area was 29.8 ± 6.2 cm2. Ablation protocol was adjusted to the clinical and electrophysiological status of the patients. Pulmonary vein isolation and bidirectional cavo-tricuspid isthmus block were performed in all patients. In addition, left atrial linear lesions were created and complex fragmented atrial potentials were ablated in patients with persistent and long-persistent AF, as well as during repeated procedures. At 12 months, stable sinus rhythm (SR) was present in 16 (53%) patients, significantly more frequently in patients with paroxysmal AF (71% in SR) compared to those with persistent (57.1% in SR) or long-persistent (22% in SR) AF. A significant reduction of AF burden was observed in 85.7% of patients with paroxysmal AF, 71.4% of patients with persistent AF, and 55.5% of patients with long-persistent AF. Single procedure success rate was 33% (10 patients), and repeat ablation procedures were performed in 13 patients. No periprocedural complications occurred. Thromboembolic events were noted in 2 patients with arrhythmia recurrence during the follow-up, including stroke in 1 patient and peripheral embolism in the other patient. In both these patients, heart failure worsening was observed during these events, and anticoagulation was inadequate in one of them. Five of 16 patients in whom stable SR was observed during the follow-up were off antiarrhythmic drug therapy at final evaluation. In the other 6 patients, antiarrhythmic drug therapy was continued due to ventricular arrhythmias. Successfully treated patients more often had paroxysmal AF (successful ablation: paroxysmal AF in 10 of 16 patients; unsuccessful ablation: paroxysmal AF in 4 of 14 patients; p = 0.009) and were younger (45 ± 11.5 years vs. 52.6 ± 9.2 years; p = 0.046). In addition, a trend toward a reduced need for cardioversion at the end of the procedure was also observed in these patients (3 patients in the successful ablation group vs. 8 patients in the unsuccessful ablation group; p = 0.056). In multivariate regression analysis, paroxysmal AF was the only independent predictor of a successful outcome. Catheter ablation of AF in patients with HCM is an effective and safe therapeutic option, particularly in patients with paroxysmal AF. Effectiveness of ablation is significantly smaller in patients with persistent AF and even more so in those with long-persistent AF. Repeated procedures were often necessary. Continued antiarrhythmic drug therapy is often required due to a significant degree of atrial remodelling.


  • Left dominant arrhythmogenic cardiomyopathy — A newly defined clinical entity

    by Piotr Szymański, Anna Klisiewicz, Mateusz Śpiewak, Łukasz Szumowski, Franciszek Walczak, Piotr Hoffman


    • 1 January 2012
      • Vol. 70  (4) , 360-8

    QRS complex widening as a predictor of appropriate implantable cardioverter-defibrillator (ICD) therapy and higher mortality risk in primary prevention ICD patients.

    by Aleksander Maciąg, Andrzej Przybylski, Maciej Sterliński, Michał Lewandowski, Katarzyna Gepner, Ilona Kowalik, Paweł Derejko, Mariusz Pytkowski, Lukasz Szumowski, Hanna Szwed

    Effectiveness of implantable cardioverter-defibrillators (ICD) in patients with reduced left ventricular ejection fraction after myocardial infarction has been documented in large randomised trials. We analysed the predictive value of clinical factors at the time of implantation for adequate ICD interventions and mortality risk. We analysed 121 consecutive patients (15 women, 106 [88%] men; mean age 62 ± 10 years) with coronary artery disease in whom ICD was implanted for primary prevention between 2001 and 2007. Mean duration of follow-up was 876 ± 538 days. Forty-four (36.4%) patients had adequate ICD interventions. In the Cox analysis, wider QRS complexes (hazard ration [HR] per each 10 ms increment: 1.13, confidence interval [CI] 1.039-1.229, p = 0.0045) and younger age at the time of ICD implantation (HR per each 10 year increment: 0.7, CI 0.5-0.9, p = 0.0081) were associated with a higher probability of adequate intervention. Wider QRS complexes were associated with a higher probability of electrical storm (HR 1.059, CI 1.014-1.045, p = 0.0002). During follow-up, 21 (17.4%) patients died. In the Cox analysis, wider QRS complexes (HR per each 10 ms increment: 1.123, CI 1.011-1.248, p = 0.0306 [in univariate analysis only]), older age at the time of implantation (HR per each 10 year increment: 1.7, CI 1.1-2.8, p = 0.0396) and higher NYHA class (HR 4.4, CI 1.7-11.5, p = 0.0022) were associated with increased mortality. Mortality was reduced by previous revascularisation (HR 0.3, CI 0.1-0.7, p = 0.006). Patients with wider QRS complexes at the time of ICD implantation had a higher probability of adequate device intervention and mortality risk. QRS complex widening was also associated with a higher incidence of electrical storm.


    • 1 January 2012
      • Vol. 70  (12) , 1313-5

    [Wide spectrum of arrhythmias, with inductions and terminations of atrio-ventricular replica-nodal tachycardia by automaticity during successful radiofrequency ablation of long anterogradely slow conducting atrio-fasciculo-ventricular accessory pathway].

    by Robert Bodalski, Lukasz Szumowski, Franciszek Walczak

    Mahaim syndrome is still a challenge. The specific characteristics of the pathway, the fact that it seldom occurs, and ambiguities about the pathophysiology and nomenclature make it, for electrophysiologists, still difficult to ablate. We present a case of a patient with anterogradely slow conducting accessory pathway, which has been effectively ablated although M potential was not observed nor was a mechanical conducting block of the accessory pathway. The accessory pathway showed a wide spectrum of electrophysiological characteristics of the "AV node physiology" including inductions and terminations of atrio-ventricular replica-nodal tachycardia by local automaticity, not only during electrophysiological study, but during successful application. The accessory pathway presented signs of two types of pseudo Mahaim fibers: atrio-fascicular and slow conducting atrio-ventricular connection.

    • 1 January 2011
      • Vol. 69  (10) , 1091-4

    [Reentrant ventricular tachycardia treated with RF ablation delivered through coronary sinus - a case report].

    by Jacek Kuśnierz, Paweł Derejko, Karol Król, Aleksander Bardyszewski, Katarzyna Byczkowska, Lukasz J Szumowski, Robert J Gil, Franciszek Walczak

    A case of a 58 year-old man with epicardially located reentrant ventricular tachycardia treated with RF ablation delivered through coronary sinus is presented. Based on multiple electrophysiological parameters (surface ECG, electroanatomical map collected from the endocardium, bipolar and unipolar endocardial recordings, and unsuccesful ablation attempts from the endocardial side) the tachycardia loop was found to be located epicardially. This allowed for successful ablation approach.

    • 1 December 2010
      • Vol. 68  (12) , 1408-11

    [12-year follow-up of a patient after successful ablation of incessant fascicular tachycardia with biventricular heart failure and severe sinus node dysfunction].

    by Franciszek Walczak, Joanna Zakrzewska-Koperska, Waldemar Bobkowski, Lukasz Szumowski, Robert Bodalski, Ewa Szufladowicz

    We present a case of a 14 year-old boy with a incessant fascicular tachycardia with retrograde conduction and tachycardiomyopathy. Verapamil, adenosine, lignocaine and repeated cardioversions were unsuccessful in termination of tachycardia. Amiodarone however caused sinus node dysfunction and temporary electrode pacing had to be used. The patient underwent successful radiofrequency catheter ablation in the area of the left posterior fascicle. Because of ventricular extrasystoles (with QRS morphology resembling that of fascicular VT) the patient underwent second ablation which significantly reduced the number of ventricular beats. The course of subsequent 12-year follow-up was uneventful.

  • Recurrence of RVOT PVCs with a Marked Shift of Its Exit Point. Gradual Elimination of Arrhythmogenic Focus by Multisite Approach

    by Paweł Derejko, Michał Orczykowski, Łukasz J. Szumowski, Franciszek Walczak

    We present a case of recurrent outflow tract arrhythmia despite repeated ablations. Premature ventricular contractions (PVCs) morphology suggested a right‐sided focus. However, electrograms preceding PVCs were recorded from the right and left outflow tracts, distal coronary sinus, and right sinus of Valsalva. Arrhythmia was eliminated after radiofrequency (RF) applications delivered from different sites. We conclude that, in patients with recurrent outflow tract PVCs, mapping all the sites mentioned above may be necessary to find the earliest activation site and carry out successful ablation. In some patients, RF applications from multiple sites may be necessary to completely eliminate arrhythmia. (PACE 2012; 35:e6–e9)